Skip to content

Homoeopathic treatment for increased levels of lipid in blood.

Clinical Study on The Utility of Individualized Homoeopathic Medicines in The Management of Dyslipidemia Using Repertorium Homoeopathicum Syntheticum. - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/067237
Enrollment
30
Registered
2024-05-13
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E785- Hyperlipidemia, unspecified

Interventions

Intervention1: Individualized homoeopathic medicines with lifestyle modification.: Intervention planned as after obtaining consent, and proper case taking of all enrolled patients will be done in a s

Sponsors

Dr Pankaj soni
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient of age 25 year to 60 year of either sex. 2.Patient giving consent to participate. 3.Patients fulfilling the Diagnostic Criteria based on clinical presentation. Diagnostic criteria Dyslipidemia is characterized by fasting: 1.Total cholesterol-more than 200 mg/dl. 2.Low density lipoprotein more than 130 mg/dl. 3.Triglyceride-more than 150 mg/dl. 4.High density lipoprotein less than 40 mg/dl.

Exclusion criteria

Exclusion criteria: 1.Patient of age less than 25 years and above 60 years. 2. Continuous use of drugs that affect lipid metabolism. 3.Patient suffering from serious illness such as stroke, Myocardial infarction, chronic kidney disease and their complication. 4.Patient not willing to give consent. 5.Patients undergoing Allopathic medication for Dyslipidemia. 6.Self-reported immuno compromised state.

Design outcomes

Primary

MeasureTime frame
To compare the changes in the value of Lipid profile before and after the Homoeopathic treatment using Repertorium Homoeopathicum Syntheticum in management of Dyslipidemia as per NCEP. (NATIONAL CHOLESTEROL EDUCATION PROGRAM) Cholesterol Guidelines: Timepoint: 3 months

Secondary

MeasureTime frame
To assess the quality of life in patients with Dyslipidemia using ORIDL. (Outcome Related to Impact on Daily Living) Timepoint: 15 days

Countries

India

Contacts

Public ContactDr Pankaj Soni

State National Homoeopathic Medical College And Hospital, Lucknow

shashankgoga@rediffmail.com9300493521

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026